Form D · Pharmaceuticals
Iterum Therapeutics plc
Dublin, L2 · CIK 0001659323
Offering snapshot reported Jul 7, 2020 · SEC filing
- Reported sold
- $2.83M Offering amount: $2.83M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 2, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 7, 2020 | Initial | $2,832,102 | No comparison | 8 | SEC filing |
| Jun 12, 2020 | Initial | $2,844,627 | No comparison | 8 | SEC filing |
| Mar 2, 2018 | Amendment | $78,097,985 | $32,230,492vs Jun 1, 2017 | 17 | SEC filing |
| Jun 1, 2017 | Initial | $45,867,493 | No comparison | 17 | SEC filing |
| Dec 30, 2016 | Amendment | $47,639,999 | $23,849,998vs Dec 2, 2015 | 13 | SEC filing |
| Dec 2, 2015 | Initial | $23,790,001 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $350K
- Finders' fees
- $0
- Form D file number
- 021-370375
Warrants to purchase 1,686,343 shares of common stock with exercise price of $1.42 per share and warrants to purchase 236,088 shares of common stock at an exercise price of $1.8531 per share. Total amounts assume full exercise.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Jul 7, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brenton K. Ahrens | Director |
| Louise Barrett | Executive |
| Mark Chin | Director |
| Michael Dunne | Executive |
| Paul R. Edick | Director |
| Corey N. Fishman | Director, Executive |
| James I. Healy | Director |
| Patrick J. Heron | Director |
| Robert Hopfner | Director |
| Ronald M. Hunt | Director |
| David Kelly | Director |
| Shahzad Malik | Director |
| Judith M. Matthews | Executive |
| Tracy Saxton | Director |
| Jeff Schaffnit | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Block 2 Floor 3, Harcourt Centre Harcourt Street
Dublin, L2, 2
Dublin, L2, 2